ArticleInternational journal of epidemiology2021
Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery.
Abstract read
In one paragraph
Article in International journal of epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort.The Journal of clinical investigation · 2026Article
- Evolutionary dynamics of HIV-1 recombinants: analysis of contemporary and historical viral populations in East Africa.Virology journal · 2026Article
- Article
- BeyondFrontiers in genetics · 2026Review
- Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rate.Virus evolution · 2026Article
- Subtype AD Recombinant HIV-1 Transmitted/Founder Viruses Are Less Sensitive to Type I Interferons than Subtype D.Viruses · 2025Article
- Article
- Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa.Frontiers in microbiology · 2025Article
- Comparison of viral phenotype and inflammatory biomarker responses in acute HIV-1 subtype A and C infections.Frontiers in microbiology · 2025Article
- Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.Nature communications · 2024Article
- Staging of immuno-virological dynamics during acute HIV infection in a Belgian prospective cohort study.Journal of virus eradication · 2024Article
- HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study.Open forum infectious diseases · 2024Article
- Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.The Journal of antimicrobial chemotherapy · 2024Article
- Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.Frontiers in immunology · 2023Article
- Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A.IJID regions · 2022Article
- A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.PLoS pathogens · 2022Article
- Article
- Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.Frontiers in immunology · 2022Article
- The importance of partnerships in accelerating HIV vaccine research and development.Journal of the International AIDS Society · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Matt A PriceIAVI, New York, USA & Nairobi, Kenya.
William KilembeRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Eugene RuzagiraMedical Research Council, Uganda Virus Research Institute, and London School of Hygiene and Tropical Medicine Uganda Research Unit (MULS), Entebbe & Masaka, Uganda.
Etienne KaritaRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Mubiana InambaoRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Eduard J SandersKenyan Medical Research Institute-Wellcome Trust, Kilifi, Kenya.
Omu AnzalaKAVI-Institute of Clinical Research, Nairobi, Kenya.
Susan AllenRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Vinodh A EdwardThe Aurum Institute, Johannesburg and Rustenburg, South Africa.
Pontiano KaleebuMedical Research Council, Uganda Virus Research Institute, and London School of Hygiene and Tropical Medicine Uganda Research Unit (MULS), Entebbe & Masaka, Uganda.
Patricia E FastIAVI, New York, USA & Nairobi, Kenya.
Wasima RidaBiostatistics Consultant, Arlington, VA, USA.
Anatoli KamaliIAVI, New York, USA & Nairobi, Kenya.
Eric HunterRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Jianming TangDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Shabir LakhiRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Gaudensia MutuaKAVI-Institute of Clinical Research, Nairobi, Kenya.
Linda Gail BekkerDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Ggayi Abu-BakerMedical Research Council, Uganda Virus Research Institute, and London School of Hygiene and Tropical Medicine Uganda Research Unit (MULS), Entebbe & Masaka, Uganda.
Amanda TichacekRwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
Paramesh ChettyIAVI, New York, USA & Nairobi, Kenya.
Mary H LatkaThe Aurum Institute, Johannesburg and Rustenburg, South Africa.
Pholo MaenetjeThe Aurum Institute, Johannesburg and Rustenburg, South Africa.
Heeran MakkanThe Aurum Institute, Johannesburg and Rustenburg, South Africa.
Jonathan HareIAVI Human Immunology Laboratory, Imperial College, London, UK.
Freddie KibengoMedical Research Council, Uganda Virus Research Institute, and London School of Hygiene and Tropical Medicine Uganda Research Unit (MULS), Entebbe & Masaka, Uganda.
Fran PriddyIAVI, New York, USA & Nairobi, Kenya.
Elise LandaisIAVI, New York, USA & Nairobi, Kenya.
Kundai ChinyenzeIAVI, New York, USA & Nairobi, Kenya.
Jill GilmourIAVI Human Immunology Laboratory, Imperial College, London, UK.
Funding
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0MVirology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0MCTL and HIV Polymorphisms in Heterosexual TransmissionR01AI064060 · NIAID · EMORY UNIVERSITY · PI GOEPFERT, PAUL A., HUNTER, ERIC · 2005 to 2019
$21.7MVirologic Correlates of Heterosexual TransmissionR37AI051231 · NIAID · EMORY UNIVERSITY · PI HUNTER, ERIC · 2008 to 2017
$9.6MViral correlates of neutralizing antibody responseU19AI090970 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI POIGNARD, PASCAL · 2010 to 2014
$9.3MEMORY AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW001042 · FIC · EMORY UNIVERSITY · PI DEL RIO, CARLOS · 1998 to 2013
$6.8MCouples HIV Counseling &Testing in two African capitalsR01MH066767 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLEN, SUSAN A · 2002 to 2006
$6.1MFamily Planning Promotion in HIV Infected ZambiansR01HD040125 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLEN, SUSAN A. · 2001 to 2005
$4.2MFIC NIH HHS D43 TW001042Medical Research Council MC_UU_00027/1NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI064060NIAID NIH HHS R37 AI051231NIAID NIH HHS U19 AI090970NICHD NIH HHS R01 HD040125NIH HHS P51 OD011132NIMH NIH HHS R01 MH066767
Abstract
PubMed holds no abstract for this paper.
Indexed as
HIV InfectionsVaccinesAfricaCohort StudiesHumansSouth AfricaVaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.